Boron Neutron Capture Therapy is a cancer treatment of cellular targeted heavy-ion therapy. It has demonstrated compelling responses for recurrent or refractory cancers, including head and neck cancers, glioblastoma, osteosarcoma, melanoma, liver caners and has been successful in treating cancer patients for whom other treatment options have been exhausted.
Established in 2014, Neuboron is the first and the only total solution provider and manufacture of AB-BNCT on earth.
National key projects
Patent application
1st AB-BNCT center in China
We have internationally exclusive and advanced technologies including accelerator-based BNCT system, treatment planning software with independent Monte Carol engine, patient positioning system, facility design, and targeted boron drugs.
